Abstract | OBJECTIVES: METHODS: Fifty-three women with urogenital symptoms were randomized to local vaginal treatment of 25 microg estradiol tablet or 1 g of conjugated estrogen cream for 12 weeks. They were assessed for urogenital symptoms, vaginal health index, vaginal cytology, endometrial thickness and estradiol level. RESULTS: Forty-eight women completed the treatment. Both groups showed improvement of urogenital symptoms, vaginal health index, and vaginal cytology after the first 4 weeks of treatment. Conjugated estrogen cream showed superior efficacy in alleviating vaginal dryness and dyspareunia. Two cases of endometrial proliferation were noted. CONCLUSIONS:
Estradiol vaginal tablet and conjugated estrogen cream were effective in treating urogenital symptoms, the restoration of normal vaginal epithelium and reduction of vaginal pH in postmenopausal women. However, 2 cases of endometrial proliferation were noted.
|
Authors | J Manonai, U Theppisai, S Suthutvoravut, U Udomsubpayakul, A Chittacharoen |
Journal | The journal of obstetrics and gynaecology research
(J Obstet Gynaecol Res)
Vol. 27
Issue 5
Pg. 255-60
(Oct 2001)
ISSN: 1341-8076 [Print] Australia |
PMID | 11776507
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Estrogens, Conjugated (USP)
- Tablets
- Vaginal Creams, Foams, and Jellies
- Estradiol
|
Topics |
- Administration, Intravaginal
- Endometrium
(drug effects)
- Estradiol
(therapeutic use)
- Estrogens, Conjugated (USP)
(therapeutic use)
- Female
- Humans
- Middle Aged
- Postmenopause
- Tablets
- Urethritis
(drug therapy)
- Vagina
(cytology, drug effects)
- Vaginal Creams, Foams, and Jellies
- Vaginitis
(drug therapy)
|